EUROFINS SCIENT Total Liabilities 2018-2024 | ERFSF
- EUROFINS SCIENT total liabilities for the quarter ending June 30, 2024 were $5.725B, a 3.14% increase year-over-year.
- EUROFINS SCIENT total liabilities for 2024 were $5.956B, a 4.32% decline from 2023.
- EUROFINS SCIENT total liabilities for 2023 were $6.225B, a 12.91% increase from 2022.
- EUROFINS SCIENT total liabilities for 2022 were $5.513B, a 0.1% increase from 2021.
EUROFINS SCIENT Annual Total Liabilities (Millions of US $) |
|
---|---|
2024 | $5,956 |
2023 | $6,225 |
2022 | $5,513 |
2021 | $5,507 |
2020 | $5,551 |
2019 | $5,516 |
2018 | $5,295 |
2017 | $3,787 |
2016 | $0 |
2015 | $0 |
EUROFINS SCIENT Quarterly Total Liabilities (Millions of US $) |
|
---|---|
2023-06-30 | $5,725 |
2022-12-31 | $5,513 |
2021-12-31 | $5,507 |
2021-06-30 | $5,483 |
2020-12-31 | $5,551 |
2020-06-30 | $5,078 |
2019-12-31 | $5,516 |
2019-06-30 | $5,563 |
2018-12-31 | $5,295 |
2018-06-30 | $4,042 |
2017-12-31 | $3,787 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.036B | $7.522B |
Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.728B | 26.96 |
Elevance Health (ELV) | United States | $94.145B | 12.15 |
CVS Health (CVS) | United States | $81.986B | 10.19 |
Cencora (COR) | United States | $53.983B | 18.77 |
Natera (NTRA) | United States | $21.477B | 0.00 |
DiDi Global (DIDIY) | China | $21.462B | 32.57 |
BioMerieux (BMXMF) | France | $15.263B | 0.00 |
Solventum (SOLV) | United States | $12.941B | 13.70 |
Revvity (RVTY) | United States | $11.610B | 19.98 |
Doximity (DOCS) | United States | $11.396B | 59.26 |
ICON (ICLR) | Ireland | $11.324B | 10.53 |
CochLear (CHEOY) | Australia | $11.195B | 0.00 |
Viatris (VTRS) | United States | $10.516B | 3.61 |
Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
Avantor (AVTR) | United States | $8.859B | 12.87 |
HealthEquity (HQY) | United States | $8.361B | 41.13 |
Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
Sotera Health (SHC) | United States | $3.832B | 21.77 |
Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
Concentras Parent (CON) | United States | $2.771B | 16.01 |
Organon (OGN) | United States | $2.264B | 2.41 |
Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
Premier (PINC) | United States | $2.101B | 14.38 |
Progyny (PGNY) | United States | $1.886B | 41.51 |
PACS (PACS) | United States | $1.698B | 0.00 |
GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
Agilon Health (AGL) | United States | $1.229B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
CareDx (CDNA) | United States | $0.911B | 14.23 |
AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
Embecta (EMBC) | United States | $0.725B | 4.89 |
QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
Nutex Health (NUTX) | United States | $0.689B | 13.50 |
Enhabit (EHAB) | United States | $0.530B | 43.58 |
InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
LifeMD (LFMD) | United States | $0.389B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
SBC Medicals (SBC) | United States | $0.359B | 0.00 |
Beauty Health (SKIN) | United States | $0.220B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
Oncology Institute (TOI) | United States | $0.193B | 0.00 |
DocGo (DCGO) | United States | $0.147B | 24.08 |
Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
So-Young (SY) | China | $0.087B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
KindlyMD (KDLY) | United States | $0.082B | 0.00 |
OncoCyte (OCX) | United States | $0.080B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
Biodesix (BDSX) | United States | $0.053B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
ModivCare (MODV) | United States | $0.018B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |